Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

4 trials in Phase 3/4

Results Transparency

0 of 8 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4

3(42.9%)

N/A

2(28.6%)

Phase 1

1(14.3%)

Phase 3

1(14.3%)

7Total

Phase 4(3)

N/A(2)

Phase 1(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT00242944Phase 4Completed

Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-ACS)

Role: collaborator

NCT01042730Not ApplicableCompleted

Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy With Pitavastatin in Coronary Artery Disease (REAL-CAD)

Role: collaborator

NCT01261234Not ApplicableCompleted

Carotid Artery Stenting With Cilostazol Addition for Restenosis

Role: collaborator

NCT03644784Completed

Protocoled Quantitative Assessment of Aortic Regurgitation Using Videodensitometry in a Multicontinental Trial in Rotterdam, Montreal, Yamaguchi, Segeberg, Amsterdam.

Role: collaborator

NCT02327832Phase 1Unknown

Safety Study of Liver Regeneration Therapy Using Cultured Autologous BMSCs

Role: lead

NCT00134472Phase 3Completed

Therapeutic Hypothermia for Severe Traumatic Brain Injury in Japan

Role: lead

NCT01223586Completed

Extended Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome

Role: collaborator

NCT00135551Phase 4Completed

Benidipine-based Comparison of Angiotensin Receptors, β-blockers, or Thiazide Diuretics in Hypertensive Patients

Role: collaborator

NCT00839449Phase 4Completed

Eicosapentaenoic Acid Cerebral Vasospasm Therapy Study

Role: lead

NCT00453596Unknown

Analysis of Implantation Failure and Establishment of Therapy for Implantation Failure

Role: lead

All 10 trials loaded